Skip to content
Menu

Cantor Fitzgerald Initiates Coverage On Immunic with Overweight Rating

Benzinga Newsdesk 4 weeks ago

Analyst RatingsNewsInitiation

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.

Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.

Read at benzinga.com